研究報告：2019年

前のページに戻る

1.       Koike H, Katsuno M, Sobue G: New teased-fibre definitions represent specific mechanisms of neuropathy. J Neurol Neurosurg Psychiatry. 90: 124, 2019

2.       Ando T, Torii R, Kazuta T, Endo T, Araki A, Horiuchi T, Terao S, Katsuno M: Hereditary Angioedema Type 1 with Recurrent Dizziness. Intern Med. 58: 1961–1963, 2019

3.       Halievski K, Nath SR, Katsuno M, Adachi H, Sobue G, Breedlove SM, Lieberman AP, Jordan CL: Disease Affects BDNF Expression in Synaptic and Extrasynaptic Regions of Skeletal Muscle of Three SBMA Mouse Models. Int J Mol Sci. 20: 1314, 2019

4.       Ikenaka K, Atsuta N, Maeda Y, Hotta Y, Nakamura R, Kawai K, Yokoi D, Hirakawa A, Taniguchi A, Morita M, Mizoguchi K, Mochizuki H, Kimura K, Katsuno M, Sobue G: Increase of arginine dimethylation correlates with the progression and prognosis of ALS. Neurology. 92: e1868–e1877, 2019

5.       Seki M, Uruha A, Ohnuki Y, Kamada S, Noda T, Onda A, Ohira M, Isami A, Hiramatsu S, Hibino M, Nakane S, Noda S, Yutani S, Hanazono A, Yaguchi H, Takao M, Shiina T, Katsuno M, Nakahara J, Matsubara S, Nishino I, Suzuki S: Inflammatory myopathy associated with PD-1 inhibitors. J Autoimmun. 100: 105–113, 2019

6.       Hashizume A, Katsuno M, Suzuki K, Banno H, Takeuchi Y, Kawashima M, Suga N, Mano T, Araki A, Hijikata Y, Hirakawa A, Sobue G; JASMITT study group: Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials. J Neurol. 266: 1211–1221, 2019

7.       Ando T, Iijima M, Fukami Y, Nishi R, Ikeda S, Yokoi S, Kawagashira Y, Koike H, Muro Y, Katsuno M: Vasculitic neuropathy with anti-phosphatidylserine/prothrombin complex antibody. Muscle Nerve. 59: E44–E46, 2019

8.       Koike H, Katsuno M: Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights. Biomedicines. 7: 11, 2019

9.       Senda J, Araki K, Tachi Y, Watanabe H, Kawagashira Y, Ito M, Atsuta N, Katsuno M, Watanabe H, Sobue G: Acute Unilateral Isolated Oculomotor Nerve Palsy in an Adult Patient with Influenza A. Intern Med. 58: 433–436, 2019

10.     Iwase T, Yoshida M, Hashizume Y, Yazawa I, Takahashi S, Ando T, Ikeda T, Nokura K: Intracranial vascular calcification with extensive white matter changes in an autopsy case of pseudopseudohypoparathyroidism. Neuropathology. 39: 39–46, 2019

11.     Yoritaka A, Ohtsuka C, Maeda T, Hirayama M, Abe T, Watanabe H, Saiki H, Oyama G, Fukae J, Shimo Y, Hatano T, Kawajiri S, Okuma Y, Machida Y, Miwa H, Suzuki C, Kazama A, Tomiyama M, Kihara T, Hirasawa M, Shimura H, Oda E, Ito M, Ohno K, Hattori N: Randomized, double-blind, multicenter trial of hydrogen water for Parkinson’s disease. Mov Disord. 33: 1505–1507, 2018

12.    Hirayama M, Ito M, Minato T, Yoritaka A, LeBaron TW, Ohno K: Inhalation of hydrogen gas elevates urinary 8-hydroxy-2’-deoxyguanine in Parkinson’s disease. Med Gas Res. 8: 144–149, 2019

13.     Sato T, Terasawa Y, Higa H, Matsuno H, Arai A, Omoto S, Mitsumura H, Toyoda C, Koike H, Iguchi Y: Nerve Ultrasound, Electrophysiological, and Clinical Changes in Treatment-Naïve Chronic Inflammatory Demyelinating Polyneuropathy: A Case Report. J Clin Neurophysiol. 36: 82–84, 2019

14.     Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Teshima R, Inamura T, Nishino I, Aoki M. Late phase II/III study of BYM338 in patients with sporadic inclusion body myositis (RESILIENT): Japanese cohort data. Rinsho Shinkeigaku. 59: 806-813, 2019

15.     Atsuta N, Nakamura R, Hayashi N, Tohnai G, Katsuno M, Sobue G. The Role of Patient Registry in the Care and Therapeutic Development for Patients with Amyotrophic Lateral Sclerosis: JaCALS. Brain Nerve. 71: 1215-1225, 2019

16.     Tanaka S, Hashizume A, Hijikata Y, Yamada S, Ito D, Nakayama A, Kurita K, Yogo H, Banno H, Suzuki K, Yamamoto M, Sobue G, Katsuno M. Nasometric Scores in spinal and bulbar muscular atrophy - Effects of palatal lift prosthesis on dysarthria and dysphagia. J Neurol Sci. 407: 116503, 2019

17.     Senda J, Ito K, Kotake T, Kanamori M, Kishimoto H, Kadono I, Nakagawa-Senda H, Wakai K, Katsuno M, Nishida Y, Ishiguro N, Sobue G. Cilostazol use is associated with FIM cognitive improvement during convalescent rehabilitation in patients with ischemic stroke: a retrospective study. Nagoya J Med Sci. 81: 359-373, 2019

18.     Kano Y, Kato H, Koike H, Katsuno M, Oguri T, Yuasa H. Multiple mononeuropathy associated with systemic sclerosis with vasculitis confirmed by nerve biopsy: a case report. Rinsho Shinkeigaku. 59: 604-606, 2019

19.     Mizuno Y, Shinoda K, Watanabe M, Ogata H, Isobe N, Matsushita T, Yamasaki R, Tanaka K, Koike H, Katsuno M, Kira JI. Intractable axonal neuropathy with multifocal peripheral nerve swelling in neuromyelitis optica spectrum disorders: A case report. Mult Scler Relat Disord. 35: 16-18, 2019

20.     Iida M, Sahashi K, Kondo N, Nakatsuji H, Tohnai G, Tsutsumi Y, Noda S, Murakami A, Onodera K, Okada Y, Nakatochi M, Tsukagoshi Okabe Y, Shimizu S, Mizuno M, Adachi H, Okano H, Sobue G, Katsuno M. Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy. Nat Commun. 10: 4262, 2019

21.     Sekine SI, Kaneko M, Tanaka M, Ninomiya Y, Kurita H, Inden M, Yamada M, Hayashi Y, Inuzuka T, Mitsui J, Ishiura H, Iwata A, Fujigasaki H, Tamaki H, Tamaki R, Kito S, Taguchi Y, Tanaka K, Atsuta N, Sobue G, Kondo T, Inoue H, Tsuji S, Hozumi I. Functional evaluation of PDGFB-variants in idiopathic basal ganglia calcification, using patient-derived iPS cells. Sci Rep. 9: 5698, 2019

22.     Ogura A, Watanabe H, Kawabata K, Ohdake R, Tanaka Y, Masuda M, Kato T, Imai K, Yokoi T, Hara K, Bagarinao E, Riku Y, Nakamura R, Kawai Y, Nakatochi M, Atsuta N, Katsuno M, Sobue G. Semantic deficits in ALS related to right lingual/fusiform gyrus network involvement. EBioMedicine. 47: 506-517,2019

23.     Ito D, Hashizume A, Hijikata Y, Yamada S, Iguchi Y, Iida M, Kishimoto Y, Moriyoshi H, Hirakawa A, Katsuno M. Elevated serum creatine kinase in the early stage of sporadic amyotrophic lateral sclerosis. J Neurol. 266: 2952-2961, 2019

24.     Hanna MG, Badrising UA, Benveniste O, Lloyd TE, Needham M, Chinoy H, Aoki M, Machado PM, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Oskarsson B, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AI, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Nishino I, Romano CD, Williams VSL, Vissing J, Auberson LZ, Wu M, de Vera A, Papanicolaou DA, Amato AA; RESILIENT Study Group. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial. Lancet Neurol. 18: 834-844, 2019

25.     Koike H, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Katsuno M, Sobue G. Evolution of amyloid fibrils in hereditary transthyretin amyloidosis: an ultrastructural study. Amyloid. 26: 6, 2019

26.     Ikenaka K, Tsukada Y, Giles AC, Arai T, Nakadera Y, Nakano S, Kawai K, Mochizuki H, Katsuno M, Sobue G, Mori I. A behavior-based drug screening system using a Caenorhabditis elegans model of motor neuron disease. Sci Rep. 9: 10104, 2019

27.     Ikenaka K, Tsukada Y, Giles AC, Arai T, Nakadera Y, Nakano S, Kawai K, Mochizuki H, Katsuno M, Sobue G, Mori I. A behavior-based drug screening system using a Caenorhabditis elegans model of motor neuron disease. Sci Rep. 9: 10104, 2019

28.     Araki K, Araki A, Honda D, Izumoto T, Hashizume A, Hijikata Y, Yamada S, Iguchi Y, Hara A, Ikumi K, Kawai K, Ishigaki S, Nakamichi Y, Tsunekawa S, Seino Y, Yamamoto A, Takayama Y, Hidaka S, Tominaga M, Ohara-Imaizumi M, Suzuki A, Ishiguro H, Enomoto A, Yoshida M, Arima H, Muramatsu SI, Sobue G, Katsuno M. TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets. J Clin Invest. 129: 3578-3593, 2019

29.     Sone J, Mitsuhashi S, Fujita A, Mizuguchi T, Hamanaka K, Mori K, Koike H, Hashiguchi A, Takashima H, Sugiyama H, Kohno Y, Takiyama Y, Maeda K, Doi H, Koyano S, Takeuchi H, Kawamoto M, Kohara N, Ando T, Ieda T, Kita Y, Kokubun N, Tsuboi Y, Katoh K, Kino Y, Katsuno M, Iwasaki Y, Yoshida M, Tanaka F, Suzuki IK, Frith MC, Matsumoto N, Sobue G. Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease. Nat Genet. 51: 1215-1221, 2019

30.     Bagarinao E, Watanabe H, Maesawa S, Mori D, Hara K, Kawabata K, Yoneyama N, Ohdake R, Imai K, Masuda M, Yokoi T, Ogura A, Taoka T, Koyama S, Tanabe HC, Katsuno M, Wakabayashi T, Kuzuya M, Ozaki N, Hoshiyama M, Isoda H, Naganawa S, Sobue G. Reorganization of brain networks and its association with general cognitive performance over the adult lifespan. Sci Rep. 9: 11352, 2019

31.     Hijikata Y, Hashizume A, Yamada S, Ito D, Banno H, Suzuki K, Sobue G, Katsuno M. 　　　Long-term Effects of Androgen Deprivation in a Patient with Spinal and Bulbar Muscular Atrophy - A Case Report with 14 Years of Follow-up. Intern Med. 58: 2231-2234, 2019

32.     Ikeda S, Koike H, Nishi R, Kawagashira Y, Iijima M, Katsuno M, Sobue G. 　　　Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating  polyradiculoneuropathy. J Neurol Neurosurg Psychiatry. 90: 988-996, 2019

33.     Riku Y, Duyckaerts C, Boluda S, Plu I, Le Ber I, Millecamps S, Salachas F; Brainbank NeuroCEB Neuropathology Network, Yoshida M, Ando T, Katsuno M, Sobue G, Seilhean D. Increased prevalence of granulovacuolar degeneration in C9orf72 mutation. Acta Neuropathol. 138: 783-793, 2019

34.     Kawabata K, Hara K, Watanabe H, Bagarinao E, Ogura A, Masuda M, Yokoi T, Kato T, Ohdake R, Ito M, Katsuno M, Sobue G. Alterations in Cognition-Related Cerebello-Cerebral Networks in Multiple System Atrophy. Cerebellum. 18: 770-780, 2019

35.     Tsuboi T, Watanabe H, Tanaka Y, Ohdake R, Sato M, Hattori M, Kawabata K, Hara K, Nakatsubo D, Maesawa S, Kajita Y, Katsuno M, Sobue G. Clinical correlates of repetitive speech disorders in Parkinson's disease. J Neurol Sci. 401: 67-71, 2019

36.     Kondo N, Tohnai G, Sahashi K, Iida M, Kataoka M, Nakatsuji H, Tsutsumi Y, Hashizume A, Adachi H, Koike H, Shinjo K, Kondo Y, Sobue G, Katsuno M. DNA methylation inhibitor attenuates polyglutamine-induced neurodegeneration by regulating Hes5. EMBO Mol Med. 11: e8547, 2019

37.     Koike H, Nakamura T,Nishi R, Ikeda S, Kawagashira Y, Iijima M, Katsuno M, Sobue G. Cardiac and peripheral vasomotor autonomic functions in hereditary transthyretin amyloidosis with non-Val30Met mutation. Amyloid. 26: 13-14, 2019

38.     Koike H, Nakamura T, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Yasuda T, Mukai E, Date Y, Shiomi K, Nakazato M, Katsuno M, Sobue G. Common clinicopathological features in late-onset hereditary transthyretin amyloidosis (Ala97Gly, Val94Gly, and Val30Met). Amyloid. 26: 24-25, 2019

39.     Yamada S, Yasui K, Kawakami Y, Hasegawa Y, Katsuno M. DEFENSIVE Stroke Scale: Novel Diagnostic Tool for Predicting Posterior Circulation Infarction in the Emergency Department. J Stroke Cerebrovasc Dis. 28: 1561-1570, 2019

40.     Adams D, Koike H, Slama M, Coelho T. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nat Rev Neurol. 15 :387-404, 2019

41.     Nakamura T, Koike H, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Katsuno M, Sobue G. Cardiovascular autonomic functions in late-onset hereditary transthyretin amyloidosis with Val30Met mutation. Amyloid. 26:6, 2019

42.     Fujishiro H, Kimura H, Nakamura T, Torii Y, Iritani S, Ozaki N. Hypochondriasis in the elderly and Lewy body disease. Psychogeriatrics. 19: 516-518, 2019

43.     Tsuboi T, Watanabe H, Katsuno M, Sobue G. Pergolide in the Treatment of Parkinson’s Disease. In: Riederer P, Laux G, Mulsant B, Le W, Nagatsu T. (eds) NeuroPsychopharmacotherapy, 2019

44.     Tsuboi T, Watanabe H, Katsuno M, Sobue G. Cabergoline in the Treatment of Parkinson’s Disease. In: Riederer P, Laux G, Mulsant B, Le W, Nagatsu T. (eds) NeuroPsychopharmacotherapy, 2019

45.     Sharma G, Huo A, Kimura T, Shiozawa S, Kobayashi R, Sahara N, Ishibashi M, Ishigaki S, Saito T, Ando K, Murayama S, Hasegawa M, Sobue G, Okano H, Hisanaga SI. Tau isoform expression and phosphorylation in marmoset brains. J Biol Chem. 294, 11433-11444,2019

46.     Abe, K. Hirayama, M. Ohno, K. Shimamura, T. ENIGMA: an enterotype-like unigram mixture model for microbial association analysis. BMC Genomics. 20: 191, 2019